lobbying_activities: 593338

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
593338	386a6699-cea6-436e-a602-cfa44874d4bb	Q1	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	3457	AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS	2008	first_quarter	PHA	Health Services and Resources Administration 340 B drug pricing program; proposed guidance on definition of patient, contract pharmacy and participation by children's hospitals. HR 3580, Food and Drug Administration Amendments Act of 2007, titles 8 and 9, all provisins. S.901. Reauthorization of National Health Service Corps. Provisions relating to loan forgiveness programs. Funding for Food and Drug Administration. HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007 and HR 1038, Access to Life Saving Medicine Act, HR 5629, Pathway for Biosimilars Act, provisions dealing with interchangability. HR 5491, Pharmacy Technician Training and Registration Act of 2008, all provisions. Proposal by FDA for a behind the counter drug category (public meeting and comments). Distribution of patient information and medication guides. Pharmacologic class in patient information. Proposal to transition Mevacor from prescription to over the counter status.	Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE		200276	0	0	2008-04-16T18:17:20-04:00